Nations Close In on Landmark Pandemic Treaty
World Health Organization member states have entered what negotiators describe as a "final stretch" of talks on a legally binding pandemic prevention treaty, with delegations working through the night in Geneva to resolve outstanding disputes over pathogen data-sharing and vaccine equity clauses.
The proposed accord, which has been under negotiation since 2021, would require countries to share samples of novel pathogens with WHO within 48 hours of detection — a provision strongly supported by low-income nations hoping to gain faster access to resulting vaccines and treatments. Wealthier countries, however, have pushed back over intellectual property concerns, arguing that pharmaceutical companies need sufficient protection to justify the cost of rapid development.
"We have come too far to let procedural disagreements derail a framework that could save millions of lives," said Dr Maria do Rosário Pinto, WHO's Director of Pandemic Preparedness, addressing delegates last Thursday. Her remarks followed a breakdown in talks that briefly threatened to push negotiations past their April deadline.
Analysts warn that without a credible enforcement mechanism, any treaty risks becoming symbolic. The COVID-19 pandemic exposed deep fractures in global health governance, with wealthy nations securing the majority of early vaccine doses while developing countries waited months for supply. Whether this agreement can translate shared urgency into binding obligation remains the defining question.